• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外阴使用粉剂与卵巢癌风险:8525 例病例和 9859 例对照的汇总分析。

Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.

机构信息

Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. doi: 10.1158/1940-6207.CAPR-13-0037. Epub 2013 Jun 12.

DOI:10.1158/1940-6207.CAPR-13-0037
PMID:23761272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3766843/
Abstract

Genital powder use has been associated with risk of epithelial ovarian cancer in some, but not all, epidemiologic investigations, possibly reflecting the carcinogenic effects of talc particles found in most of these products. Whether risk increases with number of genital powder applications and for all histologic types of ovarian cancer also remains uncertain. Therefore, we estimated the association between self-reported genital powder use and epithelial ovarian cancer risk in eight population-based case-control studies. Individual data from each study were collected and harmonized. Lifetime number of genital powder applications was estimated from duration and frequency of use. Pooled ORs were calculated using conditional logistic regression matched on study and age and adjusted for potential confounders. Subtype-specific risks were estimated according to tumor behavior and histology. 8,525 cases and 9,859 controls were included in the analyses. Genital powder use was associated with a modest increased risk of epithelial ovarian cancer [OR, 1.24; 95% confidence interval (CI), 1.15-1.33] relative to women who never used powder. Risk was elevated for invasive serous (OR, 1.20; 95% CI, 1.09-1.32), endometrioid (OR, 1.22; 95% CI, 1.04-1.43), and clear cell (OR, 1.24; 95% CI, 1.01-1.52) tumors, and for borderline serous tumors (OR, 1.46; 95% CI, 1.24-1.72). Among genital powder users, we observed no significant trend (P = 0.17) in risk with increasing number of lifetime applications (assessed in quartiles). We noted no increase in risk among women who only reported nongenital powder use. In summary, genital powder use is a modifiable exposure associated with small-to-moderate increases in risk of most histologic subtypes of epithelial ovarian cancer.

摘要

使用阴部爽身粉与某些但不是所有的流行病学研究中的上皮性卵巢癌风险相关,这可能反映了大多数这些产品中滑石颗粒的致癌作用。使用阴部爽身粉的次数是否会增加风险以及是否会增加所有组织学类型的卵巢癌风险也尚不确定。因此,我们估计了在 8 项基于人群的病例对照研究中,自我报告的阴部爽身粉使用与上皮性卵巢癌风险之间的关联。从使用持续时间和频率来估计终生使用阴部爽身粉的次数。使用条件逻辑回归进行汇总,匹配研究和年龄,并调整潜在混杂因素。根据肿瘤行为和组织学估计特定亚型的风险。纳入了 8525 例病例和 9859 例对照进行分析。与从未使用过爽身粉的女性相比,使用阴部爽身粉与上皮性卵巢癌风险略有增加(OR,1.24;95%置信区间[CI],1.15-1.33)。侵袭性浆液性(OR,1.20;95%CI,1.09-1.32)、子宫内膜样(OR,1.22;95%CI,1.04-1.43)和透明细胞(OR,1.24;95%CI,1.01-1.52)肿瘤以及交界性浆液性肿瘤(OR,1.46;95%CI,1.24-1.72)的风险升高。在阴部爽身粉使用者中,我们观察到随着终生使用次数的增加(按四分位数评估),风险无显著趋势(P=0.17)。我们没有发现仅报告非阴部爽身粉使用的女性风险增加。总之,使用阴部爽身粉是一种可改变的暴露因素,与大多数上皮性卵巢癌组织学亚型的小到中度风险增加相关。

相似文献

1
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.外阴使用粉剂与卵巢癌风险:8525 例病例和 9859 例对照的汇总分析。
Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. doi: 10.1158/1940-6207.CAPR-13-0037. Epub 2013 Jun 12.
2
Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.外阴使用粉末与卵巢癌风险的关联。
JAMA. 2020 Jan 7;323(1):49-59. doi: 10.1001/jama.2019.20079.
3
Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium.外阴使用粉末与非洲裔女性上皮性卵巢癌风险:非洲裔女性上皮性卵巢癌联盟研究
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1660-1668. doi: 10.1158/1055-9965.EPI-21-0162. Epub 2021 Jun 21.
4
Genital powder exposure and the risk of epithelial ovarian cancer.外阴粉暴露与上皮性卵巢癌风险。
Cancer Causes Control. 2011 May;22(5):737-42. doi: 10.1007/s10552-011-9746-3. Epub 2011 Mar 10.
5
Perineal powder exposure and the risk of ovarian cancer.会阴部接触粉剂与卵巢癌风险
Am J Epidemiol. 1997 Mar 1;145(5):459-65. doi: 10.1093/oxfordjournals.aje.a009128.
6
Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).使用爽身粉与卵巢癌之间的关联:非裔美国人癌症流行病学研究(AACES)
Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1411-1417. doi: 10.1158/1055-9965.EPI-15-1281. Epub 2016 May 12.
7
Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.滑石粉、爽身粉与卵巢癌:流行病学证据总结。
Gynecol Oncol. 2021 Oct;163(1):199-208. doi: 10.1016/j.ygyno.2021.07.032. Epub 2021 Aug 6.
8
The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.滑石粉使用与卵巢癌之间的关联:美国两个州的一项回顾性病例对照研究。
Epidemiology. 2016 May;27(3):334-46. doi: 10.1097/EDE.0000000000000434.
9
Genital talc exposure and risk of ovarian cancer.生殖器接触滑石粉与卵巢癌风险
Int J Cancer. 1999 May 5;81(3):351-6. doi: 10.1002/(sici)1097-0215(19990505)81:3<351::aid-ijc7>3.0.co;2-m.
10
Perineal exposure to talc and ovarian cancer risk.会阴部接触滑石粉与卵巢癌风险
Obstet Gynecol. 1992 Jul;80(1):19-26.

引用本文的文献

1
Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments.通过药物重新定位革新卵巢癌治疗,实现加速且具成本效益的治疗。
Front Oncol. 2025 Jan 14;14:1514120. doi: 10.3389/fonc.2024.1514120. eCollection 2024.
2
Environment and gynaecologic cancers.环境与妇科癌症。
Oncol Rev. 2024 Oct 8;18:1430532. doi: 10.3389/or.2024.1430532. eCollection 2024.
3
Associations between common contraceptive use and circulating inflammatory biomarkers.常见避孕方法的使用与循环炎症生物标志物之间的关联。

本文引用的文献

1
Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.阿司匹林、非阿司匹林类非甾体抗炎药或对乙酰氨基酚与卵巢癌风险。
Epidemiology. 2012 Mar;23(2):311-9. doi: 10.1097/EDE.0b013e3182456ad3.
2
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.上皮性卵巢癌的分子发病机制和卵巢外起源——改变模式。
Hum Pathol. 2011 Jul;42(7):918-31. doi: 10.1016/j.humpath.2011.03.003.
3
Genital powder exposure and the risk of epithelial ovarian cancer.外阴粉暴露与上皮性卵巢癌风险。
Am J Epidemiol. 2025 Jan 8;194(1):85-94. doi: 10.1093/aje/kwae135.
4
Intimate Care Products and Incidence of Hormone-Related Cancers: A Quantitative Bias Analysis.亲密护理产品与激素相关癌症的发病:定量偏倚分析。
J Clin Oncol. 2024 Aug 1;42(22):2645-2659. doi: 10.1200/JCO.23.02037. Epub 2024 May 15.
5
Epidemiology and risk factors for ovarian cancer.卵巢癌的流行病学及危险因素
Prz Menopauzalny. 2023 Jun;22(2):93-104. doi: 10.5114/pm.2023.128661. Epub 2023 Jun 14.
6
Prevention of Epithelial Ovarian Cancer.预防上皮性卵巢癌。
Cold Spring Harb Perspect Med. 2023 Aug 1;13(8):a038216. doi: 10.1101/cshperspect.a038216.
7
Effects of risk factors for ovarian cancer in women with and without endometriosis.有无子宫内膜异位症的女性中卵巢癌的危险因素的影响。
Fertil Steril. 2022 Nov;118(5):960-969. doi: 10.1016/j.fertnstert.2022.07.019. Epub 2022 Sep 29.
8
Spatial Analysis of Shared Risk Factors between Pleural and Ovarian Cancer Mortality in Lombardy (Italy).胸膜癌和卵巢癌死亡率在伦巴第(意大利)的共享风险因素的空间分析。
Int J Environ Res Public Health. 2022 Mar 15;19(6):3467. doi: 10.3390/ijerph19063467.
9
Association Between the Frequent Use of Perineal Talcum Powder Products and Ovarian Cancer: a Systematic Review and Meta-analysis.会阴部滑石粉产品频繁使用与卵巢癌之间的关联:一项系统评价和荟萃分析
J Gen Intern Med. 2022 Aug;37(10):2526-2532. doi: 10.1007/s11606-022-07414-7. Epub 2022 Feb 2.
10
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.高预诊炎症相关风险评分与卵巢癌生存降低相关。
Cancer Epidemiol Biomarkers Prev. 2022 Feb;31(2):443-452. doi: 10.1158/1055-9965.EPI-21-0977. Epub 2021 Nov 17.
Cancer Causes Control. 2011 May;22(5):737-42. doi: 10.1007/s10552-011-9746-3. Epub 2011 Mar 10.
4
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.上皮性卵巢癌的起源和发病机制:一种提出的统一理论。
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
5
Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.卵巢癌亚型(除高级别浆液性癌外)中的分子异常。
J Oncol. 2010;2010:740968. doi: 10.1155/2010/740968. Epub 2009 Dec 30.
6
Risk factors for epithelial ovarian cancer by histologic subtype.组织学亚型的上皮性卵巢癌的风险因素。
Am J Epidemiol. 2010 Jan 1;171(1):45-53. doi: 10.1093/aje/kwp314. Epub 2009 Nov 12.
7
Ovarian cancer risk factors in African-American and white women.非裔美国女性和白人女性的卵巢癌风险因素。
Am J Epidemiol. 2009 Sep 1;170(5):598-606. doi: 10.1093/aje/kwp176. Epub 2009 Jul 15.
8
Markers of inflammation and risk of ovarian cancer in Los Angeles County.洛杉矶县炎症标志物与卵巢癌风险
Int J Cancer. 2009 Mar 15;124(6):1409-15. doi: 10.1002/ijc.24091.
9
Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.CYP19A1基因座中两个常见单核苷酸多态性与卵巢癌风险的关联。
Endocr Relat Cancer. 2008 Dec;15(4):1055-60. doi: 10.1677/ERC-08-0104. Epub 2008 Jul 30.
10
Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium.基因多态性在卵巢癌易感性中的作用:国际卵巢癌协会联盟的发展
Adv Exp Med Biol. 2008;622:53-67. doi: 10.1007/978-0-387-68969-2_5.